Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Kurch

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 8, 2024
Update on FDG-PET in pediatric lymphomaLars Kurch, Regine Kluge
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2014
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and MarthanDirk Hasenclever, Lars Kurch, Regine Kluge
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET"Regine Kluge, Sally Barrington, Lars Kurch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2016
Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30Regine Kluge, Lars Kurch, Thomas Georgi, et al.
Pediatric Radiology|March 26, 2013
FDG PET/CT in children and adolescents with lymphomaRegine Kluge, Lars Kurch, Françoise Montravers, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 2016
Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cellsStefanie Kewitz, Lars Kurch, Ines Volkmer, et al.
Nuklearmedizin. Nuclear Medicine|May 15, 2024
Superimposing kidneys in [99mTc]MAG-3 and [99mTc]DMSA-scintigraphy in a tricky case of an extensive, displacing growing retroperitoneal liposarcomaRobert Zeidler, Solveig Tiepolt, Swen Hesse, et al.
EJNMMI Research|September 15, 2021
Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphomaLars Kurch, Ulrich Dührsen, Andreas Hüttmann, et al.
Frontiers in Oncology|July 10, 2023
Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative studyPhilipp Lückemeier, Aleksandar Radujkovic, Udo Holtick, et al.
Klinische Padiatrie|October 2, 2018
Simultaneous F18-FDG-PET/MR Optimized Treatment Planning in a Young Patient with Sacro-Coccygeal ChordomaChristian Roth, Osama Sabri, Regine Kluge, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 8, 2024
Update on FDG-PET in pediatric lymphomaLars Kurch, Regine Kluge
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2014
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and MarthanDirk Hasenclever, Lars Kurch, Regine Kluge
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
Reply to: Laffon and Marthan "FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET"Regine Kluge, Sally Barrington, Lars Kurch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2016
Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30Regine Kluge, Lars Kurch, Thomas Georgi, et al.
Pediatric Radiology|March 26, 2013
FDG PET/CT in children and adolescents with lymphomaRegine Kluge, Lars Kurch, Françoise Montravers, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 2016
Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cellsStefanie Kewitz, Lars Kurch, Ines Volkmer, et al.
Nuklearmedizin. Nuclear Medicine|May 15, 2024
Superimposing kidneys in [99mTc]MAG-3 and [99mTc]DMSA-scintigraphy in a tricky case of an extensive, displacing growing retroperitoneal liposarcomaRobert Zeidler, Solveig Tiepolt, Swen Hesse, et al.
EJNMMI Research|September 15, 2021
Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphomaLars Kurch, Ulrich Dührsen, Andreas Hüttmann, et al.
Frontiers in Oncology|July 10, 2023
Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative studyPhilipp Lückemeier, Aleksandar Radujkovic, Udo Holtick, et al.
Klinische Padiatrie|October 2, 2018
Simultaneous F18-FDG-PET/MR Optimized Treatment Planning in a Young Patient with Sacro-Coccygeal ChordomaChristian Roth, Osama Sabri, Regine Kluge, et al.
Pageof 7